Automated Plate Handlers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The automated plate handlers market is expected to grow at a CAGR of 3.56% during the forecast period (2020-2025). Research labs and academic institutions are increasingly opting for modular automation solutions, wherein they can reduce human intervention in tedious and repetitive tasks.

Key Highlights

• Automation is being used widely in various life science applications ranging from drug discovery to systems biology. Automation is also an important feature in the diagnostics market. In clinical diagnostics, where profits margins are based on the number of samples, high throughput is the most important factor which is driving the market studied.
• The drastic increase in sample throughput and the significant decrease in the time to produce experimental results are the major factors driving the automated plate handlers market.
• Moreover, microplate automation instruments are used in laboratories for increased throughput and greater scale in various protocols, such as high throughput screening, next-generation sequencing, cellular analysis, PCR set-up, serial dilution, toxicology, plate labeling, and many more. Apart from reducing the mundane tasks, automated plate handlers market is also driven by the need for consistency in quality as the cost of error is very high in laboratories.

Key Market Trends

Drug Discovery Segment to Witness High Growth

• In general, a medical compound takes several years moving from a target concept to a medication that generates revenue. Furthermore, there are several phases involved in the drug discovery and development process (DDD).
• The gradual increase in costs of pharmaceutical products provoked the industry players to modernize the ongoing traditional processes. Manual procedures involved in the discovery process take a considerable amount of time and are very complex as well as expensive. Hence, drug discovery units have pivoted into automating and robotizing their research laboratories.
• During the DDD processes for new therapeutic solutions, an automated plate handler is an important tool that helps in streamlining the laboratory workflow. Procedures that used to take several months manually can now be completed in a day by the use of modular automation systems.
• Growing incidences of diseases such as cancers are requiring spending for advanced drugs. In the United States, the cancer drug development number has increased over the past few years which has stimulated the adoption of automation in the country.

North America Occupies the Largest Market Share

• In the North American region, the rate of adoption of lab automation is increasing rapidly due to the accuracy and ease of usage it provides, which is ultimately reducing human intervention and allows the doctor to reduce the throughput time and think about the implications of their experiments and to design effective follow-up projects.
• Due to the rise in the number of pre-clinical studies and also the demand for an efficient and cost-effective solution required for the analysis of various samples, the automated plate handlers market is growing in the North American region.
• Various regulations imposed by the government of the US and the food and drug administration, increasing demand in the diagnostics sector, growing importance on the drug discovery process, and with the incremental rise of various diseases such as cardiovascular diseases and neurological diseases among others in the region has boosted the market for automated plate handlers market.

Competitive Landscape

The automated plate handlers market is a highly competitive market due to the presence of many small and large players in domestic as well as international markets. The market is moderately concentrated and the key strategies adopted by the major players are mergers and acquisition, product innovation. some of the major players in the market are Siemens Healthineers AG, Becton Dickinson, Agilent Technologies, PerkinElmer among others.

• January 2018 - Agilent Technologies acquired Luxcel Biosciences to expand its cell analysis portfolio. Luxcel Biosciences develops real-time fluorescence plate-reader based in-vitro cell assay kits.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support